As the global medical industry rapidly shifts toward personalization and precision, 3D printing technology has emerged as a key driver of transformative innovation in the medical device sector, capitalizing on its unique strengths in “complex structure fabrication, rapid prototyping, and on-demand customization.” In recent years, 3D printing, integrated with biocompatible materials, multimodal imaging, and AI algorithms, has seen successful applications in orthopedic implants, surgical guides, personalized prosthetics, drug delivery systems, and bioengineered tissue scaffolds, significantly enhancing the adaptability and therapeutic outcomes of medical devices. However, the field still faces challenges such as limitations in material performance, barriers to multidisciplinary collaboration, and a lack of regulatory standardization.

To accelerate technological transformation and industrial upgrading, this conference will focus on material innovation, process optimization, and clinical validation of 3D printing, exploring its current state and future trajectory.

• Medical device manufacturers: heads of the departments of R&D, technology, as well as project/company leaders.
• Suppliers of material, design, processing technology and solution
• Clinicians, laboratories and research organizations